Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drozitumab in advanced chondrosarcoma
NCT00543712Phase 2Terminated
- Sponsor
- Genentech
- Start
- May 2007
- Primary completion
- May 2008
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of Apomab in chondrosarcoma, sponsored by Genentech. Started May 2007; status: terminated.
02
Drugs
Apomab
03
Conditions
chondrosarcoma
Beyond the preview
Go deeper on NCT00543712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543712.